Cargando…

Development of an appropriate simple suspension method for valganciclovir medication

BACKGROUND: Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC tablets have to be pulverized so that they can be delivered via nasogastric tubes. The “simple suspension method” is usually used to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Masaoka, Yasuyuki, Kawasaki, Yoichi, Kikuoka, Ryo, Ogawa, Atsushi, Esumi, Satoru, Wada, Yudai, Ushio, Soichiro, Kitamura, Yoshihisa, Sendo, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339454/
https://www.ncbi.nlm.nih.gov/pubmed/32655872
http://dx.doi.org/10.1186/s40780-020-00172-w
_version_ 1783554894919106560
author Masaoka, Yasuyuki
Kawasaki, Yoichi
Kikuoka, Ryo
Ogawa, Atsushi
Esumi, Satoru
Wada, Yudai
Ushio, Soichiro
Kitamura, Yoshihisa
Sendo, Toshiaki
author_facet Masaoka, Yasuyuki
Kawasaki, Yoichi
Kikuoka, Ryo
Ogawa, Atsushi
Esumi, Satoru
Wada, Yudai
Ushio, Soichiro
Kitamura, Yoshihisa
Sendo, Toshiaki
author_sort Masaoka, Yasuyuki
collection PubMed
description BACKGROUND: Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC tablets have to be pulverized so that they can be delivered via nasogastric tubes. The “simple suspension method” is usually used to suspend tablets in hot water in Japan. However, the optimal suspension conditions and metering methods for preparing VGC suspensions using the simple suspension method are unclear. The purpose of this study was to clarify these issues. METHODS: VGC tablets were suspended in water (initial water temperature: 25 °C or 55 °C) using the simple suspension method. The residual rate of VGC after it had been suspended in hot water was determined using HPLC. In addition, the suspended solution was passed through 6, 8, and 12 Fr. gavage tubes. The VGC concentrations of suspensions produced using different preparation methods were also determined using HPLC. RESULTS: Cracking the surfaces of VGC tablets and suspending them in water at an initial temperature of 55 °C was effective at dissolving the tablets. The VGC concentration of the suspension remained stable for at least 80 min. Furthermore, the VGC concentration remained stable for 48 h during cold dark storage. Cracking the surfaces of VGC tablets could be a more effective metering method than preparing powder from VGC tablets. In addition, little VGC remained in 6, 8, or 12 Fr. gavage tubes after VGC solution was passed through them. CONCLUSION: The amount of VGC should be measured carefully when preparing VGC solutions using the simple suspension method.
format Online
Article
Text
id pubmed-7339454
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73394542020-07-09 Development of an appropriate simple suspension method for valganciclovir medication Masaoka, Yasuyuki Kawasaki, Yoichi Kikuoka, Ryo Ogawa, Atsushi Esumi, Satoru Wada, Yudai Ushio, Soichiro Kitamura, Yoshihisa Sendo, Toshiaki J Pharm Health Care Sci Research Article BACKGROUND: Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC tablets have to be pulverized so that they can be delivered via nasogastric tubes. The “simple suspension method” is usually used to suspend tablets in hot water in Japan. However, the optimal suspension conditions and metering methods for preparing VGC suspensions using the simple suspension method are unclear. The purpose of this study was to clarify these issues. METHODS: VGC tablets were suspended in water (initial water temperature: 25 °C or 55 °C) using the simple suspension method. The residual rate of VGC after it had been suspended in hot water was determined using HPLC. In addition, the suspended solution was passed through 6, 8, and 12 Fr. gavage tubes. The VGC concentrations of suspensions produced using different preparation methods were also determined using HPLC. RESULTS: Cracking the surfaces of VGC tablets and suspending them in water at an initial temperature of 55 °C was effective at dissolving the tablets. The VGC concentration of the suspension remained stable for at least 80 min. Furthermore, the VGC concentration remained stable for 48 h during cold dark storage. Cracking the surfaces of VGC tablets could be a more effective metering method than preparing powder from VGC tablets. In addition, little VGC remained in 6, 8, or 12 Fr. gavage tubes after VGC solution was passed through them. CONCLUSION: The amount of VGC should be measured carefully when preparing VGC solutions using the simple suspension method. BioMed Central 2020-07-07 /pmc/articles/PMC7339454/ /pubmed/32655872 http://dx.doi.org/10.1186/s40780-020-00172-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Masaoka, Yasuyuki
Kawasaki, Yoichi
Kikuoka, Ryo
Ogawa, Atsushi
Esumi, Satoru
Wada, Yudai
Ushio, Soichiro
Kitamura, Yoshihisa
Sendo, Toshiaki
Development of an appropriate simple suspension method for valganciclovir medication
title Development of an appropriate simple suspension method for valganciclovir medication
title_full Development of an appropriate simple suspension method for valganciclovir medication
title_fullStr Development of an appropriate simple suspension method for valganciclovir medication
title_full_unstemmed Development of an appropriate simple suspension method for valganciclovir medication
title_short Development of an appropriate simple suspension method for valganciclovir medication
title_sort development of an appropriate simple suspension method for valganciclovir medication
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339454/
https://www.ncbi.nlm.nih.gov/pubmed/32655872
http://dx.doi.org/10.1186/s40780-020-00172-w
work_keys_str_mv AT masaokayasuyuki developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT kawasakiyoichi developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT kikuokaryo developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT ogawaatsushi developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT esumisatoru developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT wadayudai developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT ushiosoichiro developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT kitamurayoshihisa developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication
AT sendotoshiaki developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication